Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | THRA | P10827 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | PNP | P00491 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methacrylic Acid SCHEMBL43929 | 1.00 | MAPT (0.38) | MAPTKMT2ATGFBR1MEN1TDP1 | |
| Methacrylic Acid SCHEMBL9221834 | 0.86 | LSS (0.35) | KMT2ATGFBR1MEN1 | |
| Methacrylic Acid SCHEMBL3423292 | 0.86 | MAPT (0.57) | MAPTTGFBR1TDP1KDM4E | |
| Acetic Acid SCHEMBL11055551 | 0.85 | MAPT (0.45) | MAPTKMT2AMEN1THRATHRB | |
| Methacrylic Acid SCHEMBL6672880 | 0.84 | MAPT (0.36) | MAPTTGFBR1TDP1 | |
| Trolamine SCHEMBL44442 | 0.83 | MAPT (0.37) | MAPTKMT2ATGFBR1MEN1TDP1 | |
| Trolamine SCHEMBL345855 | 0.83 | MAPT (0.37) | MAPTKMT2ATGFBR1MEN1TDP1 | |
| Trolamine SCHEMBL43636 | 0.83 | MAPT (0.37) | MAPTKMT2ATGFBR1MEN1TDP1 | |
| Bicarbonate SCHEMBL10946736 | 0.82 | MAPT (0.47) | MAPTKMT2AMEN1THRATHRB | |
| Acetone SCHEMBL28041802 | 0.82 | MAPT (0.47) | MAPTKMT2AMEN1TDP1THRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122060108-A | Dispersing softening agent for lithium iron phosphate battery positive electrode, preparation method thereof, lithium iron phosphate battery positive electrode slurry and positive electrode plate prepared from lithium iron phosphate battery positive electrode slurry | 东莞市里迪科技有限公司 | 2026-05-19 | — | — | CN | disclosed |
| WO-2024096019-A1 | DENTAL ADHESIVE COMPOSITION | クラレノリタケデンタル株式会社 | 2024-05-10 | — | — | WO | disclosed |
| EP-4364718-A1 | DENTAL CURABLE COMPOSITION | Kuraray Noritake Dental Inc. (JP) | 2024-05-08 | — | — | EP | disclosed |
| WO-2024029508-A1 | KIT FOR PREPARING CURABLE COMPOSITION FOR DENTAL MATERIAL, CURABLE COMPOSITION FOR DENTAL MATERIAL, AND DENTAL MATERIAL | 三井化学株式会社 | 2024-02-08 | — | — | WO | disclosed |
| WO-2024029507-A1 | CURABLE COMPOSITION PREPARATION KIT, CURABLE COMPOSITION, CURED ARTICLE, AND DENTAL MATERIAL | 三井化学株式会社 | 2024-02-08 | — | — | WO | disclosed |
| EP-2979679-B1 | CURABLE COMPOSITION FOR DENTAL USE | KURARAY NORITAKE DENTAL INC (JP) | 2023-11-29 | — | — | EP | disclosed |
| WO-2023127794-A1 | DENTAL CURABLE COMPOSITION AND DENTAL PROSTHESIS COMPRISING BASE MATERIAL AND RESIN LAYER | クラレノリタケデンタル株式会社 | 2023-07-06 | — | — | WO | disclosed |
| WO-2023106419-A1 | DENTAL CURABLE COMPOSITION | クラレノリタケデンタル株式会社 | 2023-06-15 | — | — | WO | disclosed |
| US-20230049373-A1 | PASTE-LIKE COMPOSITION FOR DENTAL USE, AND METHOD FOR PRODUCING THE SAME | KURARAY NORITAKE DENTAL INC. (JP) | 2023-02-16 | — | — | US | disclosed |
| WO-2023277042-A1 | DENTAL CURABLE COMPOSITION | クラレノリタケデンタル株式会社 | 2023-01-05 | — | — | WO | disclosed |
| EP-2979679-A1 | CURABLE COMPOSITION FOR DENTAL USE | Kuraray Noritake Dental Inc. (JP) | 2016-02-03 | — | — | EP | disclosed |
| US-9125802-B2 | Dental curable composition | KURARAY NORITAKE DENTAL INC. (JP) | 2015-09-08 | — | — | US | disclosed |
| EP-2656831-A1 | CURABLE DENTAL COMPOSITION | Kuraray Noritake Dental Inc. (JP) | 2013-10-30 | — | — | EP | disclosed |
| US-20130274426-A1 | DENTAL CURABLE COMPOSITION | KURARAY NORITAKE DENTAL INC. (JP) | 2013-10-17 | — | — | US | disclosed |
| US-8552088-B2 | Cement for dental applications | KURARAY NORITAKE DENTAL INC. (JP) | 2013-10-08 | — | — | US | disclosed |
| US-8545225-B2 | Redox-curing type composition | KURARAY NORITAKE DENTAL INC. (JP) | 2013-10-01 | — | — | US | disclosed |
| EP-2409997-A1 | REDOX-CURING TYPE COMPOSITION | Kuraray Medical Inc. (JP) | 2012-01-25 | — | — | EP | disclosed |
| US-20120016094-A1 | REDOX-CURING TYPE COMPOSITION | KURARAY MEDICAL INC. (JP) | 2012-01-19 | — | — | US | disclosed |
| US-20100267856-A1 | CEMENT FOR DENTAL APPLICATIONS | KURARAY MEDICAL INC. (JP) | 2010-10-21 | — | — | US | disclosed |
| EP-2226060-A1 | CEMENT FOR DENTAL APPLICATIONS | Kuraray Medical Inc. (JP) | 2010-09-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130274426-A1 | DENTAL CURABLE COMPOSITION | BAZ2B, BRPF3, SHH | MAPT 718/4885KMT2A 536/4885TGFBR1 2171/4885 |
| US-20230049373-A1 | PASTE-LIKE COMPOSITION FOR DENTAL USE, AND METHOD FOR PRODUCING THE SAME | PFN1, XRN2, FLNA | MAPT 1224/4885KMT2A 1700/4885TGFBR1 3688/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.